Unitil (NYSE: UTL) VP LeBlanc receives stock grants and shares vest

Rhea-AI Filing Summary

Unitil Corporation vice president Christopher J. LeBlanc reported multiple stock awards and vesting transactions dated January 27, 2026. He received two grants of 1,080 shares of common stock at no cost under Unitil’s Third Amended and Restated 2003 Stock Plan, with one grant vesting 25% per year over four years and the other tied to a three-year performance period.

He also acquired 40 shares of common stock at $50 per share, issued at the conclusion of the 2023–2025 performance period based on achieved performance goals. Following these transactions and prior dividend reinvestments, his directly held common stock position is 22,372.16 shares, and he holds 1,520 derivative (contingent) shares that may vest based on future performance conditions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LeBlanc Christopher J

(Last) (First) (Middle)

6 LIBERTY LANE WEST

(Street)

HAMPTON NH 03842

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
UNITIL CORP [ UTL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Vice President

3. Date of Earliest Transaction (Month/Day/Year)
01/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock, no par value	01/27/2026		A		1,080	A	$0(1)	0	D
Common stock, no par value	01/27/2026		A		1,080	A	$0(2)	0	D
Common stock, no par value	01/27/2026		A		40	A	$50(3)	22,372.16(4)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Contingent grant of common stock	(5)	01/27/2026		A		540		(5)	(5)	Common stock	540	(5)	1,520	D

Explanation of Responses:

1. Shares were granted pursuant to the Unitil Corporation Third Amended and Restated 2003 Stock Plan. Shares generally will vest 25% per year over four years from date of grant. Shares will be valued at current market price on date of vesting.

2. Shares were granted pursuant to the Unitil Corporation Third Amended and Restated 2003 Stock Plan. Shares generally will vest after three-year performance period based on the attainment of certain performance thresholds of certain performance goals. Shares will be valued at current market price on date of vesting.

3. Shares were granted pursuant to the Unitil Corporation Third Amended and Restated 2003 Stock Plan. Shares were granted at the conclusion of the 2023-2025 performance period based on the attainment of certain performance thresholds of certain performance goals. Shares were valued at current market price on date of grant. The balance of the contingent grant for such performance period terminated.

4. Includes 44.268 shares of common stock acquired on February 28, 2025, 46.552 shares of common stock acquired on May 30, 2025, 53.116 shares of common stock acquired on August 28, 2025 and 50.729 shares of common stock acquired on November 28, 2025, in each case resulting from the reinvestment of dividends pursuant to Unitil Corporation's Dividend reinvestment and Stock Purchase Plan.

5. Shares may be granted pursuant to the Unitil Corporation Third Amended and Restated 2003 Stock Plan.Any such shares would be granted after a three-year performance period ending on December 31, 2028, based on the attainment of certain performance thresholds of certain performance goals. Any such shares would be valued at current market price on date of grant.

	/s/ Thomas P. Meissner, Jr., attorney-in-fact for Christopher J. LeBlanc	01/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did Unitil (UTL) report for Christopher LeBlanc?

Unitil reported that vice president Christopher J. LeBlanc received two grants of 1,080 common shares at no cost and 40 shares at $50 per share. These awards reflect time-based and performance-based stock granted under the company’s Third Amended and Restated 2003 Stock Plan.

How many Unitil (UTL) shares does Christopher LeBlanc hold after this Form 4?

After the reported transactions, Christopher J. LeBlanc directly holds 22,372.16 shares of Unitil common stock. This total includes shares accumulated through dividend reinvestment, along with the newly issued stock associated with the completion of the 2023–2025 performance period.

What are the vesting terms of the new Unitil (UTL) stock grants to LeBlanc?

One 1,080-share grant generally vests 25% per year over four years from the grant date. The second 1,080-share grant generally vests after a three-year performance period, based on achieving specified performance thresholds tied to defined performance goals under the stock plan.

What does the 40-share Unitil (UTL) grant at $50 represent for LeBlanc?

The 40 shares at $50 per share were granted at the conclusion of the 2023–2025 performance period. They were awarded based on the attainment of certain performance thresholds, valued at the current market price on the grant date, with the remaining contingent grant for that period terminating.

What contingent Unitil (UTL) stock awards does Christopher LeBlanc hold?

LeBlanc holds 1,520 derivative (contingent) shares under the Unitil stock plan. These may be granted after a three-year performance period ending December 31, 2028, depending on whether specified performance thresholds and goals are met, and would be valued at market price on the grant date.